Germline PGX molecular testing
Active Awarded Last action
- Contract number
- 36C10X26N0165
- Awardee
-
Fulgent Therapeutics LLC UEI JVZDRESJLD82 Part of Fulgent Genetics, Inc.
- Awarding agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Obligated
- $6,574
Award facts
- Contract value <1% obligated
- $6,573,600.00 Current and potential, with all options
- Completion date 10% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21703, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Strategic Acquisition Center Frederick issued a $6.573 million delivery order to Fulgent Therapeutics LLC on September 30, 2026, under the Germline PGx Services indefinite delivery contract for germline pharmacogenomic molecular testing supporting the Veterans Health Administration National Oncology Program, with performance completion by September 29, 2027.
The Germline PGx Services IDIQ, issued by VA Strategic Acquisition Center Frederick on September 30, 2024, carries a $99.032 million ceiling through September 29, 2029, and supplies germline genetic and pharmacogenomic testing services to the VA system. Place of performance is Frederick, MD. This delivery order represents Year 2 within-scope modification activity under the parent vehicle. The order is priced firm fixed price with no set-aside designation. Fulgent Therapeutics operates as a self-performing laboratory service provider delivering all work through its own personnel; SCI-reportable federal contracts show the vendor invoiced $19.9 million across FY2022–FY2025 with zero subcontractor hours, and FTE headcount expanded from 1.2 FTEs in FY2022 to 13.4 FTEs in FY2025, reflecting growing oncology testing scope. Median government-paid hourly rates on SCI-reportable contracts run $199.88 per hour.
Quick answers
Who was awarded contract 36C10X26N0165?
36C10X26N0165 was awarded to Fulgent Therapeutics LLC by VA Strategic Acquisition Center Frederick (Headquarters) on September 30, 2026.
How much is contract 36C10X26N0165 worth?
The government has obligated $6,574 on 36C10X26N0165. Its current value, with exercised options, is $6,573,600.
Is contract 36C10X26N0165 an order under another contract?
Yes. 36C10X26N0165 is a delivery order under 36C10X24D0028, an indefinite delivery contract, on Germline PGx Services.
Was contract 36C10X26N0165 competed?
The extent of competition for 36C10X26N0165 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award